Atossa Therapeutics Inc (NASDAQ:ATOS)
| 1.53 Delayed Data As of Jan 17 |  +0.01 / +0.66%Today’s Change | 1.19 Today|||52-Week Range 7.39 | -2.55% Year-to-Date |
Latest ATOS News | Press Releases
No recent news for Atossa Therapeutics Inc.
Today’s Trading
| Previous close | 1.52 |
| Today’s open | 1.52 |
| Day’s range | 1.50 - 1.53 |
| Volume | 67,888 |
| Average volume (3 months) | 109,779 |
| Market cap | $14.0M |
Data as of 3:47pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | +49.60% |
| Earnings growth (this year) | +47.64% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.38 |
Competitors
Data as of 8:00pm ET, 01/17/2020
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$11.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
